Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - FREE CASH FLOW
Free Cash Flow REPL - Replimune Group, Inc.
-191 M
LAST VALUE
-50.38%
2 YEAR CAGR
-46.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR